Metabolomics is an innovative approach to the treatment and diagnosis of chronic diseases. Increased adoption of metabolomics in drug development and personalized healthcare is expected to fuel the market growth during the forecast period.
The biomarker discovery segment contributed to the highest market share in 2017 and will maintain its dominant share during the forecast period. Advancements in quantification methods & technologies along with rising in concerns regarding the prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer would fuel the growth of this segment.
The report provides an extensive analysis of the global metabolomics market based on product & service, application, indication, and geography. Based on product & service, the report segments the market into metabolomics instruments and metabolomics bioinformatics tools & services. The application segment is further classified into biomarker discovery, toxicology testing, drug discovery, functional genomics, nutrigenomics, personalized medicine, and others. Based on indication, the report bifurcates the market into cancer, neurological disorders, cardiovascular disorders, inborn errors of metabolism, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The Global Metabolomics Market is expected to garner $3.30 billion by 2023, growing a CAGR of 13.2% from 2017 to 2023. North America contributed the highest market share in 2017; while, Asia-Pacific is expected to experience the highest growth rate during the forecast period.
The report offers insights on drivers, restraints, and opportunities of the global metabolomics market. A surge in the adoption of metabolomics in precision medicine and a rise in R&D investments are expected to facilitate market growth. In addition, technological advancements for auxiliary medical devices utilized for analysis of metabolomics and a rise in demand for quality medications supplements the growth of the market. However, expensive medical devices and lack of effective data management for the profiling of metabolomics restrain market growth.
Get sample Report @ https://www.alliedmarketresearch.com/request-sample/525
Key Findings of the report:
- The drug discovery segment is anticipated to witness the highest growth rate during the forecast period.
- The biomarker discovery segment generated the highest market share in 2017 and is expected to maintain its dominance during the forecast period.
- North America dominated the global metabolomics market in 2017.
- China would register the highest CAGR in the Asia-Pacific region.
North America held the major market share in 2017, owing to a surge in R&D investments and the availability of advanced healthcare facilities. In addition, a rise in usage of experimental medicines and the increase in the adoption of metabolomics for precision medicine fuel the growth. However, Asia-pacific would grow at the highest CAGR during the forecast period owing to the increase in the adoption of metabolomics in medical research and an increase in government initiatives for finding cost-effective treatments for chronic diseases.
The key companies analyzed in the report include Agilent Technologies, Inc., Biocrates Life Sciences AG, Danaher Corporation, Leco Corporation, Bruker Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc., Shimadzu Corporation, Bio-Rad Laboratories, Inc., Waters Corporation, and Thermo Fisher Scientific Inc.
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060